Psychopharmacology Buster (Plan B)

Psychopharmacology Buster (Plan B)

₹23000.00₹19000.00

Welcome to Psychopharmacology, Buster!

Plan B = 18 + 2 = 20 months

A deep-dive series dedicated to exploring psychopharmacology and neurotherapeutics—where science meets clinical wisdom.

Each episode features in-depth, evidence-based discussions on psychiatric medications, mechanisms of action, clinical applications, side-effect profiles, and the latest advances in treatment strategies.

SECTION I:

FOUNDATIONS OF PSYCHOPHARMACOLOGY

  • Origins of Psychotropic Drug Development

  • Paradigm Shifts in Psychiatric Treatment

  • From Serendipity to Rational Drug Design

  • Principles of Pharmacokinetics & Pharmacodynamics

  • Agonism, Antagonism, and Partial Agonism

  • Receptor Theory and Signal Transduction

  • Neurotransmitters**: Two sides of the coin

  • Classification of Psychotropics : pros and cons

SECTION II:

PSYCHOPHARMACOLOGY OF MAJOR PSYCHIATRIC DISORDERS

Antipsychotic Drugs

  • Typical and Atypical Antipsychotics (Each Drug in detail)

  • Mechanisms of Action and Clinical Efficacy

  • Adverse Effects

  • Clinical Pearls

  • Precise selection of antipsychotic agents in different scenarios (Real Case Scenarios)

Antidepressant Drugs

  • All classes of antidepressants (Each Drug in detail)

  • Novel antidepressants and Rapid-acting antidepressants (Ketamine & others)

  • Mechanisms of Action and Clinical Efficacy

  • Adverse Effects & Clinical Pearls

  • Precise selection of antidepressant agents in different scenarios (Real Case Scenarios)

Mood Stabilizers

  • All Mood Stabilizers (Each Drug in detail)

  • Mechanisms of Action and Clinical Efficacy

  • Adverse Effects

  • Clinical Pearls

  • Precise selection of mood stabilizers agents in different scenarios (Real Case Scenarios)

Anxiolytics and Hypnotics

  • Benzodiazepines and Z-Drugs

  • Non-GABAergic Anxiolytics

  • DORA’s, Melatonin, Etifoxine

  • Adverse Effects

  • Clinical Pearls

  • Precise selection of anxiolytics, sedatives, and hypnotic agents in different scenarios (Real Case Scenarios)

SECTION III:

SPECIAL POPULATIONS AND CLINICAL CONTEXTS

Psychopharmacology in Children and Adolescents

  • Developmental Considerations

  • Safety, Efficacy, and Long-Term Outcomes

  • Approach to each disorder in depth

Psychopharmacology in Geriatric Psychiatry

  • Age-Related Pharmacokinetic Changes

  • Co-morbid conditions and rational psychopharmacological approach

Psychopharmacology in Pregnancy and Lactation

  • Bodily changes in pregnancy

  • Teratogenicity and Perinatal Risk Assessment

  • Clinical Decision-Making Frameworks

Substance Use Disorders

  • Neurobiology of Addiction

  • Trait-based approach to treatment of addiction

  • Pharmacotherapy protocol for management of individual substance

Psychopharmacology in Medical and Neurological Illness

  • Drug-Drug Interactions

  • Neuropsychiatric Manifestations of Systemic Disease and their treatment

  • Anti-Seizure Medication

  • Drugs used in Parkinson’s Disease

  • Treatment of Movement Disorder (Approach to Movement Disorder)

  • Delirium: The Conundrum resolved

SECTION IV:

ADVERSE EFFECTS, SAFETY, AND MONITORING

  • Adverse Drug Reactions in Psychopharmacology

  • Metabolic, Cardiovascular, and Endocrine Effects

  • Extrapyramidal Syndromes

  • Pharmacovigilance and Therapeutic Drug Monitoring

  • Clinical Laboratory Monitoring (Serum level monitoring)

References: 

  • CTP 11 Ed

  • Kaplan & Sadock 12th Ed

  • Tasman Psychiatry 5th Ed

  • APA Textbook of Psychopharmacology 6th Ed

  • Stahl’s Psychopharmacology, 5th Ed

  • Green’s Child & Adolescent Clinical Psychopharmacology

  • Psychopharmacology: Drugs, The Brain & Behaviour

  • The Wiley-Blackwell Handbook of Addiction Psychopharmacology by James MacKillop

  • Drugs and Pregnancy by Brett Little

  • Meyler’s side effects of Psychiatric Drugs

  • The Clozapine and Lithium Handbook

  • Articles: Nature, JAMA, MDPI, IJP, IJPM, CINP, etc.

Whether you’re a psychiatry resident, clinician, or mental health enthusiast, this series will help you understand the “why” behind psychopharmacological decisions—from neurotransmitters to neural networks.

FAQ:

  • Both live and recorded sessions will be made available to you all

  • Special guest lectures will be done by experts in their respective fields.

  • Workbooks will be provided to you all.

  • Those who have enrolled in FINAL STRIKE 1.0, 2.0, 3.0 don't need to buy this course, as it will be provided to you for free

  • Doubt discussion will be held on regular intervals.